This is a demo store. No orders will be fulfilled.

PP2, FYN 原癌基因抑制剂; Src 家族酪氨酸激酶; LCK 原癌基因抑制剂; Src 家族酪氨酸激酶

Src Inhibitors
有货

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
P408365-1ml
1ml 现货 Stock Image
查看相关系列
Compound libraries (12333)

基本描述

英文别名 AG 1879,AGL 1879 | 1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-
规格或纯度 Moligand™, 10mM in DMSO
英文名称 PP2
生化机理 PP2(AG 1879,AGL 1879)是一种 Src 家族激酶抑制剂,对 Lck/Fyn 有很强的抑制作用,在无细胞实验中的 IC50 为 4 nM/5 nM,对表皮生长因子受体的抑制作用要低约 100 倍,对 ZAP-70、JAK2 和 PKA 没有活性。
储存温度 -80℃储存
运输条件 超低温冰袋运输
作用类型 抑制剂
作用机制 FYN 原癌基因抑制剂; Src 家族酪氨酸激酶; LCK 原癌基因抑制剂; Src 家族酪氨酸激酶
产品介绍

PP2(AGL 1879) 是可逆的ATP竞争性的Src家族抑制剂,对p56lck,p59fynT,Hck和Src的IC50分别为4,5,5和100 nM。An effective and selective inhibitor of Src family kinases

Information

PP2 PP2 (AG 1879, AGL 1879), a Src family kinase inhibitor, potently inhibits Lck/Fyn with IC50 of 4 nM/5 nM in cell-free assays, ~100-fold less potent to EGFR, inactive for ZAP-70, JAK2 and PKA.
In vitro

PP2 inhibits Src by binding to an area of the molecule that does not overlap with the ATP binding domain. PP2 (20 μM) induces 40-50% growth inhibition of HT29 cells, this concentration reduces the Src activity as early as 1 hour and maintains a 35% inhibition of Src activity for 2 days. PP2 (100 mM) decreases the Src activity of HT29 cells in a dose-dependent manner. PP2 (1 mM-100 mM) causes a dose-dependent growth inhibition of human colon cancer cells (HT29, SW480, and PMCO1), liver cancer cells (PLC/PRF/5, KYN-2, Li7, and HepG2), and breast cancer cells (MCF-7, MDA-MB-468, and BT-474). PP2 (20 μM) significantly increases aggregation in most of the cancer cells (HT29, SW480, PMCO1, PLC/PRF/5, KYN-2, Li7, MCF-7, and MDA-MB-468) in E-cadherin dependent manner. PP2 (20 μM) enhances E-cadherin expression and also strongly increases E-cadherin’s association with the actin cytoskeleton in cancer cells. PP2 (20 μM) increases the expression of α-catenin, β-catenin, and γ-catenin in HT29 cells, whereas in PLC/PRF/5 and MCF-7 cells, the total protein level of α-catenin does not change, but the levels of β- catenin and γ-catenin increases slightly. PP2 inhibits proliferation of two cervical cancer cells (HeLa and SiHa) in a time- and dose-dependent manner. PP2 (10 μM) down-regulates pSrc-Y416, pEGFR-Y845, and -Y1173 expression levels in HeLa and SiHa cells. PP2 (10 μM) could modulate cell cycle arrest by up-regulating p21(Cip1) and p27(Kip1) in both HeLa and SiHa cells and down-regulating expression of cyclin A, and cyclin dependent kinase-2, -4 (Cdk-2, -4) in HeLa and of cyclin B and Cdk-2 in SiHa.

In vivo

PP2 (5 mg/kg/day) induces some slowing in the growth rate of the primary tumors relative to the control treated with vehicle in SCID mice inoculated HT29 cells in the spleen. PP2 (5 mg/kg/day) induces some slowing in the growth rate of the primary tumors relative to the control treated with vehicle in SCID mice inoculated HT29 cells in the spleen. PP2 (5 mg/kg/day) significantly reduces the relative liver weight and liver metastasis volume compared with the controls in SCID mice inoculated HT29 cells in the spleen. PP2 (1.5 mg/kg i.p.) treated rats show approximately 50% reduction of infarct size on T2-weighted MRI and in TTC staining compared with controls in rats with focal ischemic brain injury. PP2 (1.5 mg/kg i.p.) results in better the neurological score than controls in rats with focal ischemic brain injury.
Cell Data

cell lines:CEM/VLB100, P388/ADR, MCF7/ADR, 2780AD, and UCLA-P3.OO3VLB cells

Concentrations:~100 μM

Incubation Time:2 days

Powder Purity:≥99%

关联靶点(人)

CYP1A2 Tchem 细胞色素 P450 1A2(Cytochrome P450 1A2) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
SRC Tclin 原癌基因酪氨酸蛋白激酶Src(Proto-oncogene tyrosine-protein kinase Src) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
FYN Tclin 酪氨酸蛋白激酶 Fyn(Tyrosine-protein kinase Fyn) (2 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
SIK2 Tchem 丝氨酸/苏氨酸蛋白激酶SIK2(Serine/threonine-protein kinase SIK2) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
RIPK2 Tchem 受体相互作用丝氨酸/苏氨酸蛋白激酶 2(Receptor-interacting serine/threonine-protein kinase 2) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
LCK Tclin 酪氨酸蛋白激酶Lck(Tyrosine-protein kinase Lck) (4 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
HCK Tclin 酪氨酸蛋白激酶HCK(Tyrosine-protein kinase HCK) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

名称和识别符

EC号 878-892-3
分子类型 小分子
Isomeric SMILES CC(C)(C)N1C2=NC=NC(=C2C(=N1)C3=CC=C(C=C3)Cl)N
关联CAS 172889-27-9
MeSH Entry Terms 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo(3,4-d)pyrimidine;AG 1879;AG1879;PP2 cpd;Src family kinase inhibitor PP2
分子量 301.77
Reaxy-Rn 9409964
Reaxys-RN link address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=9409964&ln=

化学和物理性质

折光率 1.68
沸点 493.54° C at 760 mmHg
熔点 193.32°C

安全和危险性(GHS)

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

此产品的引用文献

引用文献

1. Yijun Li, Xinyu Wen, Min Nie, Qi Wang.  (2017)  Toward Subtle Manipulation of Fine Dendritic β-Nucleating Agent in Polypropylene.  ACS Omega,  (10): (7230–7238).  [PMID:31457299] [10.1021/acsomega.7b01036]

溶液计算器